Sean N. Tucker, PhD

CSO, VP of Research
Vaxart

Disclosure(s): Vaxart Inc: Stocks/Bonds

Poster(s):

• 1960 - Mucosal rAd5 Immunization against SARS-CoV-2 Spike Elicits Cross-Reactive Nasal and Serum Neutralizing Antibodies and Protects Against Beta Variant Challenge in African Green Monkeys
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET